Nvidia's Secret Partner... This Is the New AI Chip Powerhouse

One unknown AI startup could match or even exceed AI's biggest runs in the coming years. Why? Because its technology solves the biggest problem holding back AI. It's a critical component that the industry can't advance without. This company just went public, so right now, it's under the radar.

Takeda Pharmaceutical Company Limited
NYSE:TAK
$13.23

Financials

Curr Year EPS Estimate0.85
Profit Margin0.06
Return on Assets0.01
Return on Equity0.04
Earnings Per Share0.81
Gross Profit2,201,453,000,000
Quarterly Revenue Growth-0.03

General

NameTakeda Pharmaceutical Company Limited
TickerTAK
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers-Specialty & Generic
CurrencyUSD
CountryUSA
Fiscal Year EndMarch
Full Time Employees47,495

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; and strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

Dividend

Takeda Pharmaceutical Company Limited pays out a dividend of $1.64 per share, with a dividend yield of 2.40%.

TAK's last dividend payment was made to shareholders on December 15, 2009.

They pay out 38.98% of their earnings out as a dividend.

Recent Dividends

Dec 11, 2023$0.32
Jul 10, 2023$0.31
Dec 12, 2022$0.33
Jul 11, 2022$0.33
Dec 13, 2021$0.40
Jul 12, 2021$0.41
Dec 11, 2020$0.43
Jul 6, 2020$0.42
Popular

AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst

Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.

Germany Nears Decision To Ban Huawei 5G By 2026: Report

Germany is moving towards removing Chinese technology from its 5G core network by 2026, with support from three key ministries citing national security concerns.

"America's No. 1 Retirement Stock" (Name Inside) - Ad

According to the former Goldman Sachs VP -- who wrote a best-selling book on retirement -- one single stock stands head-and-shoulders above all others. And it should be the cornerstone of your portfolio. Have you heard of it?

Stock market today: Asian shares advance after another round of Wall St records

Asian shares were mostly higher on Thursday after U.S. stocks rallied to records on hopes that back in the right direction.

Snowflake Analysts Remain Overweight: Potential Growth Despite Iceberg Adoption Concerns

Piper Sandler analyst attended Virtual Iceberg Summit with tech giants. Snowflake seen as having potential drag on growth, but threat may be overstated.

Mystery of the Rich and Connected Revealed - Ad

Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.

US prisoners are being assigned dangerous jobs. But what happens if they are hurt or killed?

PHOENIX (AP) — Blas Sanchez was nearing the end of a 20-year stretch in an Arizona prison when he was leased out to work at Hickman’s Family Farms, which sells eggs that end up in the supply chains of huge companies like McDonald’s, Target and Albertsons. While assigned to a machine that churns chicken droppings into compost, his right leg got pulled into a chute with a large spiraling augur.

The No. 1 Crypto for 2024 - Ad

It's expected to soar 20X bigger than Bitcoin.

Taiwan is selling more to the US than China in major shift away from Beijing

WASHINGTON (AP) — Whether it's tapioca balls or computer chips, Taiwan is stretching toward the United States and away from China — the world's No. 2 economy that threatens to by force if necessary.

Could Elon's New Device be Bigger than the iPhone? - Ad

According to 30-year Silicon Valley and Wall Street veteran, Eric Fry... A man who picked 41 plays that jumped 1,000%+... This mind-blowing new technology could be bigger than the iPhone. And it could make a lot of people wealthy in the coming months and years.

Top 3 Real Estate Stocks That Are Set To Fly

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down.

How to Profit From the New Boom in Gold - Ad

Gold just passed $2,000/oz and is set for a new bull run in 2024. Now a renowned precious metals expert is sharing his No. 1 way to play it for just $5.

Mysterious Gold Leverage Just Announced - Ad

Ex-Goldman Sachs VP reveals a secret of the rich and connected that lets you tap into the upside of a huge amount of real, physical gold for just a few dollars at a time. He says the upside could be near 1,000% in the coming future.

Gov. Gavin Newsom: Authorities Seized $61M In Unlicensed Cannabis Products, Plants So Far This Year

California has reported stats on its crackdown on illegal cannabis operations, with state law enforcement seizing over $61 million worth...

Trump Meets With DeSantis, Noem Stirs Up Controversy: How Will Republican Vice President Betting Odds Be Impacted?

The relationship between Donald Trump and Ron DeSantis was heated at times during the Republican primary season, before the Florida governor dropped out of the 2024 presidential election and threw his support behind the

Earn Instant Cash Flow (using THIS tactic) - Ad

Can you imagine earning $1,118,721/hr? That's what greedy Wall Street elites have been pocketing for 22 straight years. And now it's available to you.

Embed-Chart-Off The Charts-Home Inventory-For Sale, ADVISORY

OFF THE CHARTS-HOME INVENTORY — Chart. More homes are on the market than a year ago, but rising mortgage rates remain a hurdle for many. This chart is current as of 05 15, 2024 and will not update. Sources: Realtor.com; Freddie Mac. Click for a .

Why Beauty Company Coty's Shares Are Gaining Today

Coty impresses with 8% YoY sales growth in Q3 FY24, outpacing estimates. Robust performance driven by strong sales across all regions, with a notable 10% LFL revenue increase. Prestige and Consumer Beauty segments both show solid gains, contributing to overall growth.

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." - Ad

The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

Buffett Says No Other Americans Would Have Had To Pay Even A Dime In Federal Taxes If This Had Happened

Warren Buffett suggests that federal taxes will likely increase given the country's precarious fiscal position, and he expressed Berkshire's willingness to cover the tax bill it faces.

Stock Market Rally For 2024 Has Peaked, Goldman Sachs Forecasts 'Flat Return From Now Till The End Of The Year'

The stock market rally for 2024 has reached its peak, according to Goldman Sachs. The firm's chief U.S. equity strategist, David Kostin, has predicted a flat return for the S&P 500 for the remainder of the year.

America Has New Type of Money, Making Some Rich...Should You Get It? - Ad

One of America's most controversial CEOs says, "A new form of money in America is making some people (including Elon Musk, Jeff Bezos, and 17 of America's 25 wealthiest individuals), rich. It has nothing to do with gold, bitcoin, or anything like that, but it's 100% legal. The problem? Few Americans have a real understanding of how it works.

China is expected to announce new measures to fix its property crisis, spur growth

Housing prices in China slumped in the first four months of the year, although factory output rose nearly 7%, according to data released Friday, as the country prepares to announce fresh measures to reinvigorate its ailing property industry.

AI & Crypto in One $11 Investment - Ad

Right now, you can harness the power of two bull markets... Artificial intelligence and cryptos...In one simple $11 investment.

Trump Vs. Biden: New Swing State Poll Reveals Winner, One Key 2024 Election Issue Could Influence Result (Updated)

A new 2024 election poll of swing state voters shows Donald Trump with a commanding lead. One key factor could be determining the race in these markets.

America Just Hit a Grim Milestone - Ad

Nearly half of U.S. households currently hold no retirement savings. Retirement expert Dr. David Eifrig says what happens next will separate a small number of winners from a very large number of losers. Learn how to protect yourself and your money with his four simple steps that he shares right here.

Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects.

Italy's RAI journalists strike over budget streamlining, complain of censorship and media repression

ROME (AP) — Some journalists at Italy’s state-run RAI went on strike Monday to protest budget streamlining and what they said was an increasingly repressive atmosphere in Italy for media under the government of Premier Giorgia Meloni.

Discover "U.S.'s New Money" Before Biden Wins - Ad

A new form of money has emerged in America, and it's making some folks wildly rich... (Musk and Bezos both use it). Find out how you can too in this free video.

FDIC chair is grilled on Capitol Hill after report outlines agency's toxic workplace culture

WASHINGTON (AP) — Federal Deposit Insurance Corp. Chairman Martin Gruenberg sat for a second day of grilling Thursday on Capitol Hill, this time at the Senate Banking Committee, after a damning was released last week.

Alabama lawmakers approve tax breaks for businesses that help employees afford child care

MONTGOMERY, Ala. (AP) — Alabama lawmakers on Tuesday gave final approval to legislation to provide state tax breaks to businesses that help their employees afford childcare.

Billionaires Are Now FLOODING Into Gold - Ad

Ray Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5).

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service